IOCBTech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.
OXYTOCINTM
TERLIPRESINTM
DERMAZULENTM
DESMOPRESINTM
USALTM
ADIURETINTM
DUVIRA GELTM
DURATOCINTM
VISTIDETM
VIREADTM
HEPSERATM
TRUVADATM
ATRIPLATM
COMPLERATM
STRIBILDTM
GENVOYATM
VEMLIDYTM
SYMTUZATM
Here you can explore our projects which are available for co-development or licensings.
The IOCB Tech team supports management and decision-making processes in Target Research Groups of IOCB e.g. by due diligence analyses, market potential studies, and project feasibility evaluation. Moreover, the company is responsible for networking and industry partner search or negotiations of contracts and agreements in the field of intellectual property.
An integral part of IOCB Tech’s duties is the organization and development of spin-off companies on IOCB’s technology platform.
